Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lung cancer remains the leading cause of cancer-related mortality globally, necessitating the continual exploration of novel therapeutic targets. The phosphoinositide 3-kinase (PI3K) signaling pathway plays a pivotal role in oncogenic processes, including cell growth, survival, metabolism and immune modulation. This comprehensive review delineates...
Alternative Titles
Full title
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d4edf7a2eec34feab01cc1ddc7b4a117
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4edf7a2eec34feab01cc1ddc7b4a117
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-025-06144-8
